Aspen Pharmacare Holdings Limited (OTCMKTS:APNHY – Get Free Report) was the target of a large decline in short interest in the month of September. As of September 30th, there was short interest totalling 100 shares, a decline of 66.7% from the September 15th total of 300 shares. Based on an average daily volume of 300 shares, the days-to-cover ratio is presently 0.3 days.
Aspen Pharmacare Price Performance
Shares of APNHY opened at $10.93 on Friday. The company has a current ratio of 1.81, a quick ratio of 1.07 and a debt-to-equity ratio of 0.30. The stock has a 50 day simple moving average of $11.79 and a 200 day simple moving average of $12.13. Aspen Pharmacare has a 52-week low of $8.45 and a 52-week high of $13.69.
Aspen Pharmacare Cuts Dividend
The company also recently announced a dividend, which was paid on Tuesday, October 8th. Shareholders of record on Friday, September 20th were paid a $0.1202 dividend. The ex-dividend date was Friday, September 20th.
About Aspen Pharmacare
Aspen Pharmacare Holdings Limited, together with its subsidiaries, manufactures and supplies specialty and branded pharmaceutical products worldwide. It operates in Commercial Pharmaceuticals and Manufacturing segments. The company provides general anesthetics, muscle relaxants, and topical agents under the Anaesthetics brand; and a range of injectable anticoagulants with a focus on low molecular weight heparins, Xa inhibitors, and heparin derivatives under the Thrombosis brand.
Read More
- Five stocks we like better than Aspen Pharmacare
- What Are Dividends? Buy the Best Dividend Stocks
- 3 Micro-Caps Set for Major Moves: Balancing Risk and Opportunity
- Business Services Stocks Investing
- Autodesk Named a “Top Pick” by Morgan Stanley—Is It Time to Buy?
- Following Congress Stock Trades
- 4 Quirky ETFs With Big Potential for Impressive Gains
Receive News & Ratings for Aspen Pharmacare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aspen Pharmacare and related companies with MarketBeat.com's FREE daily email newsletter.